Delivery Order SPE2DB24D3015-SPE2DB25FGAEM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,676.12. The delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ingrezza 80 mg capsules, a medication used to treat a neurological condition. The contract has a ceiling value of $4,027.70 and a completion date of May 9, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating it was open to full and...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,099.22 firm fixed-price delivery order contract is for the supply of 60 mg Ingrezza capsules. Ingrezza is a specialty medication used to treat a neurological disorder. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,119.55, is for the supply of Ingrezza 40 mg capsules. The contract has an ultimate completion date of August 3, 2022 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $6,239.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg capsules of Ingrezza. Under this order, Amerisourcebergen will deliver 30 capsules of Ingrezza to a location in Conshohocken, Pennsylvania. The order has a period of performance starting on July 7, 2023 and ending on July 28, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency procures and provides logistics support for medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40 mg Ingrezza capsules, a prescription medication, with a ceiling value of $3,676.12 and a performance period through June 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,055.40 firm-fixed-price contract is for the supply of Ingrezza 80 mg capsules. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- The Defense Logistics Agency Troop Support Medical awarded a $3,119.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 mg INGREZZA capsules. Under this contract, Amerisourcebergen will deliver 30 capsules of INGREZZA, an FDA-approved treatment for tardive dyskinesia, to a location in Conshohocken, Pennsylvania by September 28, 2023. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA medical supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for the supply of INGREZZA 80 MG capsules, a medication used for the treatment of tardive dyskinesia. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,676.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ingrezza 40 mg capsules, a medication used to treat certain neurological conditions. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAEMDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents part of the company's extensive pharmaceutical supply portfolio to federal healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military, veteran, and other government healthcare systems. The parent IDC facilitates flexible delivery orders such as this one, enabling the company to support the Defense Health Agency, U.S. Coast Guard, and other federal customers through a comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/21/25 |